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ABSTRACT 
ANALYSIS OF THE IN-VITRO NANOPARTICLE-CELL 
INTERACTIONS VIA SUPPORT VECTOR REGRESSION 
MODEL  
Nur Muhammed Akbulut 
M.S. in Industrial Engineering 
Supervisor: Prof. Dr. Savaş Dayanık  
Co-Supervisor: Assoc. Prof. Dr. İhsan Sabuncuoğlu  
August 26, 2013 
 
In this research a Support Vector Regression model is developed to understand the 
nanoparticle (NP)-cell interactions and to predict the cellular uptake rate of the 
nanoparticles, which is the rate of NPs adhered to the cell surface or entered into the 
cell. Examination of nanoparticle-cell interaction is important for developing 
targeted drug delivery systems and cell-level detection and treatment of diseases. 
Cellular uptake rate of NPs depends on NP type, size, shape, surface charge, 
concentration and incubation time. Conducting numerous experiments on the 
combinations of those variables to understand NP-cell interaction is impractical. 
Hence, a mathematical model of the cellular uptake rate will therefore be useful. The 
data for this study are obtained from in-vitro NP-healthy cell experiments conducted 
by a Nano-Medicine Research Center in Turkey. The proposed support vector 
regression model predicts the cellular uptake rate of nanoparticles with respect to 
incubation time given the size, charge and concentration properties of NPs.  
 
 
 
 
 
Keywords: Nano-medicine, targeted drug delivery, nanoparticle uptake rate, support 
vector regression   
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ÖZET 
 
DESTEK VEKTÖR REGRESYON MODELİ İLE          
İN-VİTRO NANOPARTİKÜL-HÜCRE 
ETKİLEŞİMLERİNİN MODELLENMESİ  
 
 
Nur Muhammed Akbulut 
Endüstri Mühendisliği, Yüksek Lisans 
Tez Yöneticisi: Doç. Dr. Savaş Dayanık  
Yardımcı Tez Yöneticisi: Prof. Dr. İhsan Sabuncuoğlu  
Ağustos, 2013 
 
Bu araştırmada, Destek Vektör Regresyon (DVR) yöntemi ile nanopartikül-hücre 
etkileşimini inceleyen ve hücreye tutunan yani hücre yüzeyine yapışan veya hücre 
içine alınan nanopartikül (NP) oranını tahmin eden bir model geliştirilmiştir. 
Güdümlü ilaç dağıtımı sistemleri ve hücre seviyesinde hastalıkların tanı ve tedavileri 
için NP-hücre etkileşimini analiz etmek önemli bir araştırma konusudur. 
Nanopartiküllerin hücreye bağlanma oranları NP tipi, boyutu, şekli, yüzey yükü, 
yoğunluğu ve zaman değişkenlerine bağlı olarak farklılık göstermektedir. NP-hücre 
ilişkisini açıklamak için bu değişkenlerin binlerce varyasyonunu deneylerle test 
etmek pratik değildir.  Bu yüzden, farklı varyasyonlar için nanopartiküllerin hücreye 
tutunma oranlarını matematiksel bir model yardımı ile tahmin etmek önemli bir 
çalışmadır.  Çalışma için kullanılan veri seti Türkiye'de bir Nano-Tıp Araştırma 
Merkezi tarafından yapılan in-vitro NP-hücre etkileşimi deneyleri sonucunda elde 
edilmiştir. Geliştirilen DVR modeli, nanopartiküllerin verilen büyüklük, yoğunluk, 
yüzey yükü özelliklerini girdi olarak alarak; nanopartiküllerin hücreye tutunma 
oranlarını zamana bağlı olarak tahmin etmektedir.    
 
 
 
 
 
Anahtar Sözcükler: Nano-tıp, güdümlü  ilaç dağılımı, hücre içine nanopartikül alım 
oranı, destek vektör regresyon modeli, tahmin modeli 
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Chapter 1 
 
Introduction 
 
Cancer causes the body cells become abnormal and divide and grow 
uncontrollably. Cancer cells may invade any tissue of the body and may spread 
through the blood or lymphatic system to other parts of the body. If this spread is not 
controlled, it can result in death. According to the World Cancer Report of The 
International Agency for Research on Cancer 7.6 million which is nearly one in eight 
of all deaths in the world is caused by cancer in 2008. According to the report this 
number will almost be doubled in 2030 [1].  National Cancer Institute’s Surveillance 
Epidemiology and End Results (SEER) program claimed that there are 12.5 million 
people who suffer from cancer only in United States by 2009 [2].  
Therefore, researchers work hard to find effective ways of diagnosis and 
treatment of cancer. Surgical operations, radiation and chemotherapy are the current 
treatment methods for cancer. However, those methods have severe side effects on 
the body. Those methods often harm healthy cells and cause toxicity. Cancer cells 
may also reappear in the body after the treatment.  
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Nanotechnology is an emerging and evolving technology and there have been 
an interest in using it in cancer research. Targeted drug delivery system is one of the 
most fundamental research areas related to both nanotechnology and biotechnology 
[3]. Targeted drug delivery is a method of delivering medication to the body in a 
manner such that the concentration of the medication in the diseased tissues is higher 
than that in the healthy cells.  Current research focuses on using nanoparticles with 
pharmacological agents to kill cancer cells in a targeted drug delivery system. Since 
those studies are conducted at cell-level, a careful investigation of nanoparticle (NP)-
cell interaction and cellular uptake efficiency, which is defined as the rate of NPs 
adhered to the surfaces of the cells or entered into the cells is very important for 
targeted drug delivery. 
Cellular uptake efficiency is affected by size, type (chemical structure), shape, 
surface charge and the concentration of NPs.  It is impractical or too costly to 
conduct all of the possible configurations of those variables in laboratory conditions.  
Therefore, this thesis aims to develop a prediction model based on data from in-vitro 
NP-cell interaction experiments. The proposed model predicts the cellular uptake rate 
of NPs on different combinations. In this study, the prediction model is developed by 
using Support Vector Regression (SVR) technique. SVR approach is preferred 
because it is a powerful tool to model non-linear complex systems. Since SVR 
presents a solution by means of small subset of training data, it also gives enormous 
computational advantages.  
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Data for this study are obtained from  in-vitro experiments that are conducted 
by a Nano-Medicine Research Center in Turkey. Silica, polymethyl methacrylate 
(PMMA) and polylactic acid (PLA) are the types of nanoparticles used in those 
experiments. Data include the uptake rate of nanoparticles for different combinations 
of NP size, charge and concentration at particular times. Then we propose a 
prediction model for 48 hours incubation period by using SVR method on those data.     
The primary contribution of this study is a prediction method for the uptake 
rate of NPs in the nanomedicine field.  The second contribution is a thorough 
implementation of SVR for statistics field based on real data.  
The remainder of the thesis is organised as follows: The related literature is 
reviewed in Chapter 2. Chapter 3 introduces Support Vector Regression. The design 
of the experiments is discussed in Chapter 4. The proposed models and results of 
computational study are presented in Chapter 5. Chapter 6 compares and discusses 
the results of our model with those of the previous studies. Finally, Chapter 7 
concludes the thesis.    
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Chapter 2 
 
Literature Review 
 
There are numerous experimental studies on nanoparticle-cell interaction and 
cellular uptake rate of nanoparticles in the literature. In those studies, effects of some 
characteristics of NPs such as chemical structure, size, surface charge, concentration 
and incubation time on the interaction with cells are explored. Although those studies 
give information about the effects of some NP characteristics on cell interactions,  
mathematical models built on those findings are very rare.  
Chitrani et al. [4] investigated the influence of different size and shape of 
colloidal gold nanoparticles for different incubation times over intracellular uptake 
inside mammalian cells. In their study, spherical NPs with diameters of 14, 30, 50, 
74 and 100 nm and rod-shaped NPs with dimensions 40x14 nm and 74x14 nm are 
used. They conclude that, uptake rate rapidly increases for the first 2 hours, and then 
becomes steady at 4-7 hours for different sizes. Their experiments also show that 
uptake rate for 50 nm NPs is higher than that for other sizes. Shape also has impact 
on uptake rate. They demonstrated that more spherical NPs are taken into the cell 
than the rod-shaped NPs. Therefore, their research demonstrates that desired cellular 
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uptake rate may be achievable by adjusting the size and shape of the NPs. However, 
the findings of their study are observational and did not lead to a mathematical model 
of  the NP-cell interaction.  Davda and Labhasetwar [5] examine the NP-endothelial 
cell interaction. They observe that the cellular uptake of nanoparticles depends on the 
incubation time and uptake rate increases with increase in the concentration of 
nanoparticles in the medium. Their study sheds light on the biocompability of the 
NPs with cells. According to their study concentration of NPs have impact on uptake 
rate.  Peetla and Labhasetwar [6] investigate the interaction between endothelial cell 
membrane and nanoparticles. 20 nm and 60 nm sized polystyrene NPs of different 
surface charges are used to analyze the changes in the membrane’s surface pressure. 
The results show that positively charged 60 nm NPs increase surface pressure while 
neutral NPs reduced surface pressure and negatively charged NPs of the same size 
have no effect. However, 20 nm NPs have greater interactions with the cell for all 
surface charges. Their study does not provide a mathematical model but it is 
significant to understand how the characterizations of nanoparticles affect the 
interaction with cells.  In all those studies, NP-cell interactions are examined by only 
physical experimentations for only two or three variables, without using a proper 
mathematical model. Therefore, they are not capable of predicting cellular uptake 
rate without conducting the experiments.   
Lin et al. [7] investigate the interactions between different surface charge 
densities and signs of gold nanoparticles and cell membranes by developing coarse-
grained molecular dynamics simulation model. They reach the conclusion that 
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positively charged nanoparticles adhere to cell membrane more than negatively 
charged nanoparticles and level of penetration increases as the charge density of NPs 
increases. They show that the adhesion and penetration level can be controlled by 
adjusting the surface charges and densities.     
Boso et al. [8] provides the only mathematical model on NP-cell interaction in 
the literature. They seek to determine the optimum NP diameter that maximizes the 
NPs adhered to the diseased blood vessel walls. They conducted a parallel plate flow 
chamber in vitro experiments with spherical polystyrene NPs. They develop an 
artificial neural network model to predict the number of NPs adhering per unit area 
as a function of shear rate and NP diameter. They show that an optimal NP diameter 
exists that maximizes the number of NPs adhere to the vessel walls. This study 
considers the effects of only NP size and wall shear rate on the NP accumulation, but 
other properties of NPs such as type, shape, charge and concentration are not 
considered. Albeit the study is limited in terms of investigating factors that affect 
NP-cell interactions, this study contains a mathematical model and demonstrate that 
accurate prediction can be used effectively to minimize the number of experiments 
needed which is the motivation for this study.      
Cenk [9] and Dogruoz [10] studies have recently proposed models of NP-cell 
interactions. They investigate the effects of NP size, surface charge, concentration, 
and chemical structure on NP-cell interactions.  Those studies and our study use the 
same data to build prediction models for  the cellular uptake rate of NPs. However, 
their modeling approaches are different. Cenk [9] develops an artificial neural 
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network model whereas Dogruoz [10] uses a statistical mixed model approach. 
Chapter 6 compares the results of our study with those of Cenk [9] and Dogruoz 
[10]. 
SVR was not studied to investigate the NP-cell interactions in the past. 
However, it is applied to many real-world problems successfully. When it is 
compared to other modeling tools, SVR generalization ability shows either similar or 
significantly better performance than competing methods in most of the cases [11].  
Hence, SVR is an appropriate tool to examine NP-cell interaction. This study will be 
helpful to understand the interaction between nanoparticles and cells for the 
nanomedicine and targeted drug delivery studies. A new application area for SVR 
will contribute to the statistics literature.  
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Chapter 3 
 
Background on Support Vector Regression 
 
 Support Vector Regression (SVR) is based on statistical learning theory and 
has been developed by Vapnik [12]. This new technique provides an efficient and 
novel approach to improve generalization performance. SVR achieves good 
generalization ability by adopting a structural risk minimization principle.  Structural 
risk minimization (SRM) seeks to minimize an upper bound on the generalization 
error rather than minimize the empirical error (empirical risk minimization (ERM)) 
focused in by many of the other modeling techniques. It has been show that SRM is 
superior to ERM principle employed by other techniques such as Artificial Neural 
Networks. SVR is trained with optimization of a quadratic cost function, which 
guarantees the attainment of a global minimum.  
  The construction of SVR to estimate a regression function is based on three 
distinct characteristics of SVR. Firstly, SVR estimate the regression function using a 
set of linear functions that are defined in a high dimensional space. Secondly, SVR 
defines the regression estimation as the problem of risk minimization with respect to 
the Vapnik’s ε-insensitive loss function. Thirdly, SVR minimizes the risk function 
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consisting of the empirical error and a regularization term which is derived from the 
SRM principle. 
 The ε-insensitive loss function can be defined as: 
                       if    ( )        
  ( )                                                                            
   ( )       ,  otherwise                                     (3.1) 
This loss function defines an ε tube (Figure 1) which means, if the predicted 
value is inside the tube the loss is zero; if the predicted value is outside the tube the 
loss is the magnitude of the difference between the predicted value and data point 
and the radius, ε.  
 
Figure 1: ε-Loss function and Slack Variable ξ 
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Assume that the training data set consists of   sample {(     )   (     )}  
where   is the input and   is the output. The problem is to choose a function that 
predicts   as closely as possible with a precision of   . 
Now, let us assume a linear predictor. 
 ( )  (   )                                                                   (3.2) 
where   is an adjustable weight vector and     and   are the n-dimensional and 1-
dimensional vector space, respectively. 
The main purpose of SVR is to find a function  ( ) that gives at most  -deviation 
from   (actual output) and at the same time as flat as possible. Flatness in (3.2) can 
be achieved by seeking small  . One way of doing this is by minimizing         
which is the Euclidean norm of   [13]. Thus, convex optimization problem is to 
minimize  
 
 
|   |
 
 
subject to  
   (        )                                                             
(        )                                                   (3.3) 
The best regression line is found by solving  
   
 
 
|   |
 
  ∑(     
 )
 
   
 
subject to 
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   (        )                                                  
(        )         
                                                                    
  
       and                                                      (3.4) 
The term 
 
 
|   |
 
  is called the regularized term. The second term  ∑ (   
 
   
  
 ), is the so called empirical error (risk), which is measured by the ε-insensitive loss 
function in (3.1).   is the regularization constant determining the trade-off between 
empirical risk and regularized term. In the error term, predictions which are deviating 
by less than    or more than    are taken into account by slack variables   
  and   , 
respectively (Figure 1). Value of   should be determined by the user. One should 
note that   is not the final desired prediction of the model. It is a characteristic of the 
prediction error penalty.  In addition to  , the penalty weight   should also be 
optimally chosen by the user. If it is chosen too small, the best result is determined 
by the size of the regression weights. On the other hand, if it is chosen too large, the 
best solution will be determined by minimizing the empirical error.  
In order to solve the problem in (3.4) the following Lagrangian function is 
constructed.  
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 (                 )
 
 
 
|   |
 
  ∑(     
 )
 
   
 ∑       
 
   
   
  (        )  ∑  
          (        ) 
 
   
 ∑(       
   
 )
 
   
 
                      (3.5) 
where    is the Lagrangian and            are the Lagrangian multipliers. It follows 
from the saddle point condition that partial derivatives of   with respect to primary 
variables           have to vanish for optimality. 
                                                       ↔            ∑   (     
  
   ), 
                                                          ↔            ∑    ∑   
  
   
 
   , 
                                                          ↔    ∑    ∑ (    )
 
   
 
   , 
                          ↔  ∑   
  
    ∑ (    
 )     ,         (3.6) 
Substituting (3.6) into (3.5) yields the following dual optimization problem. 
     ∑(  
 
 
   
   )  ∑  (  
 
 
   
   )  
 
 
∑∑(     
 )(     
 )(     )
 
   
 
   
 
subject to 
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∑   ∑  
 
 
   
 
   
  
                   , 
    
                                                     (3.7) 
The coefficients   ,    
  are determined by solving (3.7). Some of these 
multipliers (  ,   
 ) will be zero. The corresponding training points are irrelevant for 
the final solution. The training objects with non-zero Lagrangian multipliers are 
called support vectors. Support vectors are the objects where prediction errors are 
larger than ±  . Then equation (3.2) can be written as; 
 ( )  ∑ (     
 )    (    )    where    
 
 
 (     )                    (3.8) 
where    denotes the collection of support vectors. 
In most problems linear regression is not appropriate. When it is not, the input data 
must be mapped into a high dimensional feature space where linear regression is 
performed through some nonlinear mapping [14]. Then   is replaced by the feature 
space representation,  ( ) in the above optimization problem. Therefore; (3.7) can 
be written as kkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkk 
     ∑(  
 
 
   
   )  ∑  (  
 
 
   
   )
 
 
 
∑∑(     
 )(     
 )( (  )  (  ))
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subject to 
∑   ∑  
 
 
   
 
 
   
 
                        
    
                                                     (3.9) 
To reduce the computational load, kernel function defined by  
 (     )   (  )  (  ) 
Cortes and Vapnik [15] introduced. 
The optimization problem can be written as  
     ∑(  
 
 
   
   )  ∑  (  
 
 
   
   )  
 
 
∑∑(     
 )(     
 ) (     )
 
   
 
   
 
subject to 
∑   ∑  
 
 
   
 
   
  
                        
    
                                                   (3.10) 
and the regression function can be written as 
 ( )  ∑ (     
 )     (    )     
where    
 
 
∑ (     
 )      (     )   (     )               (3.11) 
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SVR model provides only an estimated target value. However, we also want to 
calculate a prediction interval. In order to find prediction intervals, we use the well-
functioning approach of Lin et al. [16] as we explain now.  
We are given a set of training data   {(     )   (     )} . We suppose that  
    (  )    ,                                              (3.12) 
where and    are independent and identically distributed random noises. 
Given a test data  , the distribution of   given   and   is  (       ). This 
allows one to construct a prediction interval      ( ) such that     with a pre-
specified probability.  If we denote  ̂( ) as the estimated function based on  , then 
   ( )     ̂( )  is the out-of-sample residuals (prediction error) and     is 
equivalent to       ̂( ).   
It is proposed to model the distribution of   based on a set of out-of-sample 
residuals {  }    
  using training data  . The   ’s are generated by first conducting a 
k-fold cross validation to get   ̂          , and then setting         ̂(  ) for 
(     )  in the jth fold. It is conceptually clear that the distribution of   ’s may 
resemble that of the prediction error  . 
Lin et al. [16] propose to model    by zero-mean Gaussian and Laplace, or 
equivalently, model the conditional distribution of   given  ̂( )  by Gaussian and 
Laplace with mean  ̂( ).   
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To obtain the fitted curves using Laplace and Gaussian distributions, we first 
express the density functions of zero-mean Laplace and Gaussian with scale 
parameter  , 
                                          Laplace  ( )  
 
  
  
   
                                                (3.13) 
 
 
                                          Gaussian  ( )  
 
√   
 
   
                                            (3.14) 
 
 
Next, assuming that   are independent, we can estimate the scale parameter by 
maximizing the likelihood. For Laplace, the maximum likelihood estimate is, 
  
∑     
 
   
 
                                                                  (3.15) 
 
and for Gaussian, 
    
∑   
  
   
 
                                                               (3.16) 
 
 
Then we obtain the fitted curves by plugging these estimates into (3.13) and 
(3.14). 
After then (1-2s)100% prediction interval for   is ( ̂( )      ̂( )    )  
where    is the upper sth percentile of the corresponding probability distribution of  .  
For example, a Laplace with  ( )  as in (3.13) has         (  )  and resulting 
prediction interval for   is 
 (   (  )       (  ) ) .                                                (3.17) 
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A Gaussian with  ( ) defined in (3.12) has     
     (   ) where ( ) is the 
cumulative density function of Gaussian distribution, and the prediction interval for   
is  
 (       (   )       (   ))                          (3.18) 
In order to decide either Laplace or Gaussian for the distribution of     will be 
used, one should investigate   ’s.  Visual detection of the histogram of   ’s and fitted 
Laplace and Gaussian models, can be helpful to decide which model captures   ’s 
better.  However, this method can be subjective and may not be efficient for some 
cases. We refer the interested reader to Lin et al [16] between Gaussian or Laplace 
distribution. 
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Chapter 4 
 
Experimental Procedure of Proposed Study  
Expertise and advanced technology are used for the synthesis of nanoparticles 
to be used for diagnostics and targeted drug delivery at cell-level. In this process, 
synthesized NPs can be characterized according to targeted cell/tissue in order to find 
and enter in or adhere to targeted cell/tissue. Therapeutic agents are inserted in 
chemically or immunologically characterized nanoparticles to treat cells. Advanced 
technology enables us to place both therapeutic and diagnostic contrast agents 
together. This method, called as “theragnostic” allows cell-level treatment and 
diagnosis simultaneously.  NPs that are used for theragnostic purposes should be 
designed properly. There are five main variables of NPs for the design of a 
theragnostic purpose: type (chemical structure), shape, surface charge and 
concentration of NP solution.  
The data set for the SVR model is obtained from in-vitro nanoparticle-cell 
interaction experiments conducted by Nanomedicine Research Center. Three types of 
NPs were used for in-vitro nanoparticles-healthy cell interaction experiments: 
polymethyl methacrylate (PMMA), silica and polylactic acid (PLA).  All of those 
NPs were sphere-shaped. Two different diameter sizes (50 nm and 100 nm) were 
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used for silica and PMMA nanoparticles, and only one diameter size (250 nm) was 
used for PLA nanoparticles. For each type of nanoparticles two different surface 
charges were selected. For each type of nanoparticle, two different concentrations of 
NP solutions (0,001 mg/l and   0, 01 mg/l) were prepared for the experiments. 
Cellular uptake rate of NPs was measured at some specific times.  
In experiments, "3T3 Swiss albino Mouse Fibroblast" type of healthy cell set 
was used to interact with nanoparticles. Cells were incubated in medium containing 
10% FBS, 2 mm L-glutamine, 100 IU / ml penicillin and 100 mg / ml streptomycin 
at 37 °C with 5% CO2. After incubation, proliferating cells in the culture flask were 
passaged using PBS and trypsin-EDTA solution. Then, cells incubated for 24 hours 
were counted and placed on 96-well cell culture plates. After then, prepared solutions 
of NPs were added to those cell culture plates.  
Cells and nanoparticles interacted in in-vitro experiments by using 
micromanipulation systems in the labs established as a ''clean room'' principle. 
Transmission electron microscopy, spectrophotometric measurement methods, and 
confocal microscopy were used in order to observe NP-cell interactions and to obtain 
the data.  
There were 20 different configurations of NPs for these experiments. For Silica 
and PMMA NPs, 8 different configurations (50 or 100 nm, positive or negatively 
charged, 0.001 or 0.01 mg/l concentration); for PLA NPs 4 different configurations 
(250 nm, positive or negatively charged, 0.001 or 0.01 mg/l concentration) were 
created. Experiments were repeated six times for each configuration. In order to 
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determine NP-cell interaction behavior by time cell cultures were observed at 3, 6, 
12, 24, 36, and 48 hours of incubation. In order to find the cellular uptake efficiency 
of nanoparticles, the following steps were applied. Immediately after the incubation 
period, the number NP removed from the environment is calculated by washing the 
solution. Subtracting this number from the initially applied number of NPs gives the 
number of NPs adhered to the cell surface or penetrated into the cell. Then, by 
dividing this number to the initial number of NPs  cellular uptake efficiency is found.   
After conducting the above experiments, for 8 different configurations of Silica 
NPs, the experiments were repeated. In those experiments, measurements were taken 
at 1.5, 4, 9, 18, 30 and 42 hour of incubation in order to observe the process in time 
intervals of the first replication. Also, for two configurations of PMMA NPs (size of 
50 and 100 nm with concentration of 0.001 mg/l and positive surface charge), the 
experiments were repeated as in the first experiment set to check for the consistency 
of the results of the first replication. The raw data is graphically illustrated in 
Appendix.   
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Chapter 5 
 
Proposed Model 
In this research, we aim to model the cellular uptake rate of NPs of different 
qualities over time. For this aim, we use Support Vector Regression model, which is 
explained in Chapter 3. The proposed model is implemented in Matlab Programming 
Language.  
We fit a model for Silica, PMMA and PLA nanoparticles. Due to their different 
chemical structures, their interactions with cells show very different behavior from 
each other. The values of the input variables used in the study are given in Table 1.  
In order to apply SVR model on these data, surface charge of NPs is converted 
to numerical values. Before applying the model, data are scaled between 0 and 1 to 
increase the efficiency of SVR model. 
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Table 1:Input variables 
1. Input Variable Value 
2. Types of NPs PMMA, Silica, PLA  
3. Diameter size of NPs  
50 nm and 100 nm for PMMA and Silica 250 nm for PLA 
4. Surface charge of NPs Positive (1) and Negative (0) 
5. Concentrations of NPs 0,001 - 0,01 mg/l 
6. Incubation time  
0,3, 6, 12, 24, 36, 48 hours for PMMA, Silica and PLA 
0,1.5, 4, 9, 18, 30, 42 hours for silica 
 Output of the proposed SVR model is cellular uptake efficiency of NPs which 
is the only dependent variable of the experiments. Cellular uptake efficiency is the 
ratio of number of NPs over the cell surface or inside the cells to the initial number 
of NPs and calculated as follows: 
 
 Note that at time zero, for all type of NPs the cellular uptake rate is zero. 
Hence, the proposed SVR model should guarantee this property. Therefore, we use a 
modified version of SVR called weighted SVR that will satisfy the uptake rate will 
be zero at time zero [17].  
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Recall the objective function of (3.4). Instead of using a common penalty 
term C, we use a weight factor si for C for each data point i. Then we solve the 
following the quadratic problem, applying the same steps as in Chapter 3.  
   
 
 
|   |
 
  ∑   (     
 )       
subject to      (        )                                      
   (        )         
                                    
                      
       and                                                               (5.1) 
By the help of this new formulation; cellular uptake prediction for time zero 
can be within Ɛ neighborhood of zero. We can achieve this result by making      
for data points where time is zero and    
 
                           
 for other data 
points. 
To construct the proposed SVR models for PMMA, Silica and PLA 
nanoparticles, first we need to determine the kernel that will be used for mapping 
data to a higher dimensional space in order to get nonlinear regression model. Dibike 
et al. [18] presented some results showing that Radial Basis Function (RBF) is the 
best kernel function to be used in SVM models. We use Gaussian Radial Basis 
Function (RBF) as kernel function.  
 (     )     (           
 )    
where,   is the parameter of the function and should be determined by the user. 
Smaller values of    give a smoother regression functions.   
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We should also determine the value of penalty term       ’s and   . The 
selection of the user-defined parameters has significant effects on the performance of 
the regression function. The best parameter set (  ,  ,  ) for a given problem is 
unknown. In the first step of this research, mean square error (MSE) is used as 
performance measure for different combinations of  parameters   (  ,  ,  ). However, 
the best parameter set selected according to MSE criterion resulted in overfits the 
data. Since SVR is problem and data dependent, selection of  the parameter values 
should be based on expert opinion. Our problem is related to living organisms and 
has complex structure. Moreover, data are obtained only for seven distinct hours over 
a 48-hours interval. Therefore, for each type of nanoparticles we made search  a grid 
of  (  ,  ,  ) 11*11*11=1331 models are presented to the choice of the experts. The 
best parameter sets were chosen based on the expert opinion.   
In Sections 5.1, 5.2 and 5.3 the proposed models for PMMA, Silica and PLA 
are given, respectively. In all given models, it is seen that there is a rapid entry of 
NPs into to the cell at the beginning of incubation periods. After some time, uptake 
rate decreases and then increases again and continues to fluctuate in this manner. 
Although general behavior looks similar, the overall behavior and uptake rates 
change with the characteristics of NPs.    
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5.1. Proposed Model and Results for PMMA NP 
For PMMA NP experiments, measurements were taken at 3, 6, 12, 24, 36, 48 
hours of incubation. For each experiment sets, there are 8 different combinations of 
PMMA NPs as in Table 2. The values of the parameters for SVR models were 
determined by expert opinions and are tabulated below. 
Table 2: Experimental groups of PMMA and Silica nanoparticles 
Group  Size Charge Density  
1  50 nm  (+)  0.001 mg/l  
2  50 nm  (+)  0.01 mg/l  
3  50 nm  (-)  0.001 mg/l  
4  50 nm  (-)  0.01 mg/l  
5  100 nm  (+)  0.001 mg/l  
6  100 nm  (+)  0.01 mg/l  
7  100 nm  (-)  0.001 mg/l  
8  100 nm  (-)  0.01 mg/l  
 
Table 3: Model parameters for PMMA NPs 
Parameter       (      )     
Value 71 71000 0.001 1.347 
Figures 2 and 3 show the hourly prediction values of the proposed models for 
PMMA NPs. Mean uptake rates for each configuration over 48 hours and their 
standard deviations are given in Table 4. Model gives a good fit with mean square 
error (MSE) 0.00244 and R-squared value 0.961. Results mostly show that 
negatively charged NPs have smaller standard deviations when size and 
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concentration are constant. Positively charged NPs show large fluctuations for 
PMMA NPs. Moreover, when sizes are same, high concentration (1/100 mg/l) has 
smaller standard deviations than low concentration (1/1000 mg/l) for negatively 
charged NPs.  
Table 4: Standard deviation of mean uptake rates for PMMA 
Type PMMA 
Size 50 100 
Charge 0 1 0 1 
Concentration 0.001 0.01 0.001 0.01 0.001 0.01 0.001 0.01 
Standard deviation 
of mean uptake 
rates  
0.218 0.110 0.166 0.134 0.132 0.060 0.348 0.232 
 
In order to understand the effect of 50 nm and 100 nm sizes for negatively 
charged PMMA, hypothesis testing for the difference between two means is applied. 
Therefore, we made 50 simulation runs that depend on our prediction model. Mean 
and standard deviations of 50 samples are calculated for each hour between 0 and 48. 
By the central limit theorem, since sample size is greater than 40, each sample is 
independent simple random sampling with approximately normal distribution.  We 
utilized from two-sample t-test to understand whether there is a significant difference 
between means or not.  The hypothesis is stated as follows: 
Null hypothesis: effects of 50 nm and 100 nm are same H0: μ1 = μ2   
Alternative hypothesis: effects of 50 nm and 100 nm are not same Ha: μ1 ≠ μ2 
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Data points                  Predictions                                   95% Prediction interval  
Figure 2: PMMA 50nm predictions 
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Data points                  Predictions                                   95% Prediction interval  
Figure 3: PMMA 100nm predictions
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Significance level is 0.05 for this analysis and degrees of freedom is n-1=49. t-score 
test statistic is calculated as   
 (     )   
  
 where    and    are the means of sample 
1 and 2,   is the hypothesized difference between population means and    is the 
standard error. Standard error is computed as   √(  
    ) (  
    )
 
 where    is 
the standard deviation of sample 1,    is the standard deviation of sample 2, and   is 
the size of sample 1, and   is the size of sample 2. 
We have a two tailed test; P(t<-2.01)=0.025 and P(t>2.01)=0.025 and we 
reject null hypothesis when P-value is less than the significance level. Null 
hypothesis is rejected when t-score is either smaller than -2.01 or greater than 2.01.  
Figures 4 and 5 show the hourly t-score values for negatively charged PMMA 
NPs. In low concentration case, P-value is less than the significance level only for a 
small portion of time. Therefore, there is no clear difference between 50 nm and 100 
nm NPs. In high concentration case, t-score is always more than 2.01, which shows 
that 50 nm NPs lead to higher uptake rate. When we consider the results for a 
targeted delivery system, it is reasonable to prefer negatively charged, 50 nm and 
high concentration of PMMA NPs since they result in high uptake rate show more 
stable behavior.  
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Figure 4: t-score of size difference ((-) Charged PMMA NPs, 0.001 Concentration) 
 
 
 
Figure 5: t-score of size difference ((-) Charged PMMA NPs, 0.01 Concentration) 
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5.2. Proposed Model and Results for Silica NP 
For Silica nanoparticles, the experiments were made at two distinct times 
with different incubation periods. In the first series of experiments, measurements 
were taken at 3, 6, 12, 24, 36, 48 hours of incubation. In the second series of 
experiments, measurements were taken at 1.5, 4, 9, 18, 30, 42 hours of incubation. 
For each experiment sets, there are 8 different combinations of Silica NPs as PMMA 
NPs given in Table 2.  
Since there are two different data sets obtained at different experiment series, 
we fit two different SVR model for Silica NPs and named as Silica I and Silica II 
models. The values of the parameters for SVR models were determined by expert 
opinions and are tabulated below.  
Table 5: Silica I and Silica II model parameters for Silica NPs 
Parameter       (      )     
Silica I Value 2000 2000000 0.002 0.15 
Silica II Value 189 189000 0.001 1 
Figure 6 and 7 show the hourly prediction values of the proposed models for 
Silica NPs. Silica I model has MSE=0.01 and R-squared value=0.88 whereas Silica 
II model has MSE=0.008 and R-squared value=0.915 as performance indicators of 
models.   
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Data points  1
st
 set                  Predictions  Silica I                                               95% Prediction interval  
Data points  2
nd
 set                 Predictions  Silica II                                              95% Prediction interval  
Figure 6: Silica 50nm predictions  
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Data points  1
st
 set                  Predictions  Silica I                                               95% Prediction interval  
Data points  2
nd
 set                 Predictions  Silica II                                              95% Prediction interval  
Figure 7: Silica 100nm predictions 
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Table 6: Standard deviation of mean uptake rates for Silica 
Type Silica (Model Silica I) 
Size 50 100 
Charge 0 1 0 1 
Concentration 0.001 0.01 0.001 0.01 0.001 0.01 0.001 0.01 
Standard deviation of 
mean uptake rates  
0.156 0.175 0.179 0.195 0.188 0.178 0.180 0.184 
Type Silica (Model Silica II) 
Size 50 100 
Charge 0 1 0 1 
Concentration 0.001 0.01 0.001 0.01 0.001 0.01 0.001 0.01 
Standard deviation of 
mean uptake rates  
0.200 0.201 0.188 0.198 0.181 0.179 0.165 0.180 
Mean uptake rates for each configuration over 48 hours and their standard 
deviations are given in table above. Silica NPs have higher uptake rates than PMMA 
NPs in general. We applied two-sample t-test for difference of 50 nm and 100 nm 
sizes of Silica NPs. Same procedure is followed as conducted for PMMA NPs.  For 
(-) charged NPs we fail to reject null hypothesis for all 0-48 hours interval since t-
scores are sometimes within the range (-2.01, 2.01). However, at other times t-scores 
are mostly less than -2.01 for both models. This shows that although we fail to reject 
the null hypothesis for whole interval, 100 nm size lead to high uptake rate for most 
of the time. Same deduction is valid for the (+) charged NPs in 0.001 concentration, 
because we fail to reject the null test for some parts of the interval and for other parts 
of the interval t-score is less than -2.01. For (+) charged NPs in 0.01 concentration, t-
scores are always greater than 2.01 for Silica II model and mostly greater than 2.01 
for Silica I model. This means that 50 nm size lead to higher uptake rate for (+) 
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charged, high concentration Silica NPs. It is also seen that uptake rates are greater for 
high concentration than low concentration  with constant NP size and charge. 
 
Figure 8: t-score of size difference ((-) Charged Silica NPs, 0.001 Concentration) for Silica I 
 
 
Figure 9: t-score of size difference ((-) Charged Silica NPs, 0.001 Concentration) for Silica II 
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Figure 10: t-score of size difference ((-) Charged Silica NPs, 0.01 Concentration) for Silica I 
 
 
Figure 11: t-score of size difference ((-) Charged Silica NPs, 0.01 Concentration) for Silica II 
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Figure 12:  t-score of size difference ((+) Charged Silica NPs, 0.001 Concentration) for  
Silica I 
 
 
Figure 13:  t-score of size difference ((+) Charged Silica II NPs, 0.001 Concentration) for 
Silica II 
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Figure 14: t-score of size difference ((+) Charged Silica NPs, 0.01 Concentration)  for    
Silica I 
 
 
Figure 15: t-score of size difference ((+) Charged Silica NPs, 0.01 Concentration) for    
Silica II 
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5.3. Proposed Model and Results for PLA NP 
 Different from Silica and PMMA experiments, only one type of size (250 nm) 
was used in the PLA experiments due to technical limitations. Measurements were 
taken at 3, 6, 12, 24, 36, 48 hours of incubation. Table 7 shows the combinations of 
PLA experiments.  
Table 7: Experimental groups of PLA nanoparticles 
Group Size Charge  Density  
1  250 nm  (+)  0.001 mg/l  
2  250 nm  (+)  0.01 mg/l  
3  250 nm  (-)  0.001 mg/l  
4  250 nm  (-)  0.01 mg/l  
As done above, the values of the parameters for SVR models were 
determined by expert opinions and are tabulated below. 
Table 8: Model parameters for PLA NPs 
Parameter       (      )     
Value 500 500000 0.001 0.0014 
Figure 16 shows the hourly prediction values of the proposed models for PLA 
NPs. PLA model performs a good fit with MSE and R-squared values found as 0.004 
and 0.915 respectively. Standard deviation of mean uptake rates of hours for PLA 
NPs is given in Table 9. PLA shows fluctuations fewer than both PMMA and Silica. 
However, average of mean uptake rates is less than Silica and more than PMMA.
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Data points                  Predictions                                   95% Prediction interval  
Figure 16: PLA predictions
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Table 9: Standard deviation of mean uptake rates for PLA 
Type PLA 
Size 250 
Charge 0 1 
Concentration 0.001 0.01 0.001 0.01 
Standard deviation of mean 
uptake rates  0.119 0.128 0.113 0.122 
 
Uptake rates in high concentration are larger than in low concentration. t-test 
is applied for the difference between means of uptake rates in high and low 
concentration to prove this result. t-scores for this test are always less than -2.01 
which means that high concentration leads to higher uptake rate.  
 
 
Figure 17: t-score of concentration difference ((-) Charged PLA NPs) 
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Figure 18: t-score of concentration difference ((+) Charged PLA NPs) 
 We also conducted t-test to see the effect of charge difference on uptake rate. 
However, we obtained t-scores that are either greater than 2.01 or between 0 and 
2.01. For low concentration, after sixth hour t-scores are always greater than 2.01;  
 
 
Figure 19: t-score of charge difference (0.01 Concentration PLA NPs) 
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Figure 20: t-score of charge difference (0.001 Concentration PLA NPs) 
this means that after six hours of incubation negative charged PLA NPs have higher 
uptake rates. For high concentration we cannot conclude a general result since t-
scores are sometimes higher than 2.01 and are sometimes lower.  
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Chapter 6 
 
Comparison and Discussion 
In this study, cellular uptake rate of nanoparticles is predicted through 
Support Vector Regression Model. There are also other mathematical studies that 
investigate the NP-cell interaction and predict the cellular uptake rate. Two studies 
were made by using the same data used in our models. Therefore, it would be 
beneficial to make a comparison among those studies and our study.  
Cenk [9] developed an artificial neural network model to predict the cellular 
uptake rate. Dogruoz [10] proposed a mixed effects model for the same purpose. 
Both studies use the same data, inputs and outputs of the models are as of our model. 
Predictions of our model, Cenk’s ANN model and Dogruoz’s mixed effects model 
are shown in Figures 21-30. All three studies suggest that different NP types have 
different interactions with cells.  For PLA NPs, our predictions show similar 
behavior with other models. However, at the beginning of incubation time the rapid 
entry into the cell is more obvious in Cenk’s study than Dogruoz’s and our study. For 
PMMA NPs, predictions are similar in all models, however, Cenk’s model has less 
fluctuation than our and Dogruoz’s model. For Silica NPs, Cenk uses the two 
different data sets in the same model without differentiating them. We should not 
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combine those data sets because they may be correlated since it can be thought that 
they come from different subjects. Therefore, our and Dogruoz’s models seem more 
appropriate at this point of view. Silica predictions of Cenk’s model generally fall in 
the region between our first and second Silica models predictions. Our Silica I model 
and Dogruoz’s first replication predictions are very similar. However, our Silica II 
model predictions are more fluctuating than Dogruoz’s second replication 
predictions.  
While our and Dogruoz’s models contain prediction intervals, Cenk provides 
confidence bounds in her model. It is more reasonable to compute prediction 
intervals because we want to know that where future predictions will fall in. Also 
Cenk’s model does not guarantee the prediction at time zero will be zero since at that 
time there is no penetration whereas this problem is solved in our and Dogruoz’s 
models. Another difference in those models is that while Cenk’s model 
mathematically guarantees that the predictions will fall in 0-1 range, our and 
Dogruoz’s models are not capable of this. In Cenk’s ANN model, she uses saturated 
linear transfer function for output layer which gives the output value between 0 and 
1. Actually this property should be satisfied since the uptake rate cannot exceed 1 or 
fall below 0. In fact, there is one way of doing that, which is transforming the data 
appropriately. We can use the following transformation for the data.        (
 
   
)  
where   is the actual uptake rate and   is the corresponding value after the 
transformation. Then, we can use   values for modeling and after modeling we can 
get the uptake rate predictions by transforming back as   
  
    
. This technique will 
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mathematically guarantee that the uptake rate   predictions will be between 0 and 1. 
We tried this transformation for our study, but it did not give good results because 
SVR modeling is problem and data dependent. In our case, we have used only 7 
different time points and tried to develop a prediction model on 48 hours interval. 
Therefore, using log transformation technique gave meaningless results at some time 
points especially where we do not have data.  
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Our model,                      Data points               Predictions                                 95% Prediction interval  
Cenk’s ANN model,                                            Predictions                                 95% Confidence interval  
Figure 21: PLA predictions of our model and Cenk’s model  
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Our model,                      Data points               Predictions                                 95% Prediction interval  
Dogruoz’s mixed model,                                   Predictions                                 95% Prediction interval  
Figure 22: PLA predictions of our model and Dogruoz’s model  
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Our model,                      Data points               Predictions                                 95% Prediction interval  
Cenk’s ANN model,                                            Predictions                                 95% Confidence interval  
Figure 23: PMMA 50 nm predictions of our model and Cenk’s model  
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Our model,                      Data points               Predictions                                 95% Prediction interval  
Cenk’s ANN model,                                            Predictions                                 95% Confidence interval  
Figure 24: PMMA 100 nm predictions of our model and Cenk’s model  
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Our model,                      Data points               Predictions                                 95% Prediction interval  
Dogruoz’s mixed model,                                   Predictions                                 95% Prediction interval  
Figure 25: PMMA 50 nm predictions of our model and Dogruoz’s model  
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Our model,                      Data points               Predictions                                 95% Prediction interval  
Dogruoz’s mixed model,                                   Predictions                                 95% Prediction interval  
Figure 26: PMMA 100 nm predictions of our model and Dogruoz’s model  
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Our model Silica I,          Data points               Predictions                                 95% Prediction interval  
Our model Silica II,         Data points               Predictions                                 95% Prediction interval  
Cenk’s ANN model,                                            Predictions                                 95% Confidence interval  
Figure 27: Silica 50 nm predictions of our model and Cenk’s model  
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Our model Silica I,          Data points               Predictions                                 95% Prediction interval  
Our model Silica II,         Data points               Predictions                                 95% Prediction interval  
Cenk’s ANN model,                                            Predictions                                 95% Confidence interval  
Figure 28: Silica 100 nm predictions of our model and Cenk’s model  
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Our model Silica I,                                               Data points               Predictions                                 95% Prediction interval  
Our model Silica II,                                              Data points               Predictions                                 95% Prediction interval  
Dogruoz’s mixed model - 1st replication,                                           Predictions                                 95% Prediction interval  
Dogruoz’s mixed model - 2nd replication,                                          Predictions                                 95% Prediction interval  
Figure 29: Silica 50 nm predictions of our model and Dogruoz’s model  
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Our model Silica I,                                               Data points               Predictions                                 95% Prediction interval  
Our model Silica II,                                              Data points               Predictions                                 95% Prediction interval  
Dogruoz’s mixed model - 1st replication,                                           Predictions                                 95% Prediction interval  
Dogruoz’s mixed model - 2nd replication,                                          Predictions                                 95% Prediction interval  
Figure 30: Silica 100 nm predictions of our model and Dogruoz’s model 
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Chapter 7 
 
Conclusion 
For the treatment of many diseases such as cancer, researchers have a focus on 
targeted drug delivery systems. The main objective of this treatment method is to 
treat only cancer cells of the body. Nanoparticles are used in those systems, to kill or 
treat the cancer cells by therapeutic agents. The main advantage of those systems is 
high efficacy of treatment can be provided without harming the healthy cells of the 
body. Therefore, investigation of nanoparticle-cell interaction is important for 
targeted drug delivery systems.  
The uptake rate, which is the ratio of the NPs adhered to the cell surface or 
entered in the cell, is affected by the chemical structure, diameter size, surface charge 
and concentration of NPs and incubation time. Since all the possible NP 
characterization cannot be tested experimentally to find the ideal NP 
characterization, we build a mathematical model.  
This study develops a modified SVR model for the prediction of uptake rates 
of NPs. Predictions are made every half an hour between 0 and 48 hours. Type of the 
nanoparticles have a big effect on the uptake rates. Silica nanoparticles have higher 
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uptake rates than PMMA and PLA nanoparticles. Negatively charged NPs have more 
stable uptake rates than positively charges NPs. Also, negative surface charge is an 
effective factor on uptake rate of PMMA nanoparticles. Uptake rates of PLA and 
Silica are lower in low concentration (1/1000) than in high concentration (1/100).  
By the time this study finished, Cenk’s ANN model and Doğruöz’s Smoothing 
Splines Mixed Effect model studies were the only two studies that use the same 
factors to model the NP-cell interaction.  In future work, these studies can be 
expanded by using different modeling tools. Moreover, NP-cancer cell interactions 
could be investigated via SVR modeling. In addition, in vivo-experiments could be 
conducted and SVR modeling approach can be a useful tool to understand the NP-
cell interactions.      
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